Insmed
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $104,442 | $93,425 | $90,340 | $75,500 |
Gross Profit | 78,291 | 72,255 | 68,113 | 56,780 |
EBITDA | -243,951 | -196,560 | -275,805 | -132,609 |
EBIT | -199,282 | -278,504 | -135,460 | |
Net Income | -235,548 | -220,524 | -300,609 | -157,091 |
Net Change In Cash | 104,442 | 93,425 | 90,340 | 75,500 |
Free Cash Flow | -202,751 | -184,605 | -129,735 | -188,714 |
Cash | 555,030 | 461,451 | 1,246,799 | 595,729 |
Basic Shares | 179,021 | 173,721 | 154,702 | 148,456 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $363,707 | $305,208 | $245,358 | $188,461 |
Gross Profit | 277,965 | 239,635 | 190,232 | 144,309 |
EBITDA | -878,252 | -660,177 | -429,438 | -375,094 |
EBIT | -670,756 | -453,705 | -402,943 | |
Net Income | -913,772 | -749,567 | -481,534 | -434,654 |
Net Change In Cash | 363,707 | 305,208 | 245,358 | 188,461 |
Cost of Revenue | 358,250 | 184,959 | ||
Free Cash Flow | -705,805 | -549,535 | -410,317 | -370,591 |
Cash | 555,030 | 482,374 | 1,074,036 | 716,782 |
Basic Shares | 164,043 | 140,433 | 123,035 | 112,111 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.32 |
2024-09-30 | -$1.27 |
2024-06-30 | -$1.94 |
2024-03-31 | -$1.06 |
